Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Published:2018-05 Issue:5 Volume:29 Page:602-613
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Magnani Chiara F.¹,Mezzanotte Claudia¹,Cappuzzello Claudia¹,Bardini Michela¹,Tettamanti Sarah¹,Fazio Grazia¹,Cooper Laurence J.N.²,Dastoli Giuseppe¹,Cazzaniga Giovanni¹,Biondi Andrea¹,Biagi Ettore¹

Affiliation:

1. Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca, San Gerardo Hospital/Fondazione MBBM, Monza, Italy;

2. University of Texas, MD Anderson Cancer Center, Houston, Texas.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2017.207

Reference42 articles.

1. Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission

2. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation